GENPREX

Executives
Rodney Varner
Chairman, President & Chief Executive Officer
Catherine M. Vaczy
Executive Vice President,General Counsel & Chief Strategy Officer
Ryan M. Confer
MS, Chief Financial Officer
Mark Berger
M.D., Chief Medical Officer
Hemant Kumar
Ph.D., CPM, EMBA, Chief Manufacturing & Technology Officer
Thomas Gallagher
Esq., Senior Vice President of Intellectual Property & Licensing
David M. Schloss
Senior Vice President of Human Resources
Board
Rodney Varner
Chairman of the Board
Brent Longnecker
Board Director
Jose A. Moreno Toscano
Board Director
William Wilson
Jr., Board Director
James E. Rothman, PhD
Strategic Advisor to the Board of Directors
Contact
Website
www.genprex.com
Address
3300 Bee Cave Road, Suite 650:227 Austin, TX 78746
Twitter
twitter.com/genprex
Facebook
www.facebook.com/genprexinc
Linkdin
www.linkedin.com/company/genprex

About GENPREX

Genprex is a clinical:stage gene therapy company focused on developing life:changing therapies for patients with cancer and diabetes.